Status:

NOT_YET_RECRUITING

Personalized Vaccine for TNBC Immunotherapy

Lead Sponsor:

Universidad Nacional de Colombia

Collaborating Sponsors:

Fundación Salud de los Andes

Conditions:

Breast Cancer Female

Eligibility:

FEMALE

18-75 years

Phase:

PHASE1

Brief Summary

Due to their genetic instability, breast tumors that do not express receptors for Estrogens, Progestagens or amplify the Her2 / neu oncogene \[called triple-negative breast cancer (TNBC)\] and other t...

Eligibility Criteria

Inclusion

  • Be between 18 and 75 years of age.
  • Histologically confirmed diagnosis of primary triple negative breast carcinoma (TNBC).
  • Patients who have already been treated, either with chemo/radiotherapy and/or surgery regimens, and in whom, according to previous preclinical studies, it was possible to clearly identify tumor NEOANTIGENS expressed by their tumor.
  • Have frank venous access.
  • Have a functional status (Karnofsky Scale) greater than 70%.
  • Weight equal to or greater than 50 kilograms.
  • The chemical synthesis of at least one tumor NEOANTIGEN expressed exclusively by your tumor was successful.
  • The apheresis procedure successfully allowed the obtaining of sufficient white blood cells to obtain leukocytes necessary for functional tests and for the derivation of dendritic cells.

Exclusion

  • Active and/or uncontrolled cardiovascular disease.
  • You are pregnant or breastfeeding.
  • Has associated medical comorbidities such as diabetes or kidney failure, or coagulation disorders.
  • You have been hospitalized in the last month.
  • Has another active primary tumor except for skin tumors.
  • Patients who are linked to another clinical study.
  • Patients with a history of infectious diseases such as HIV, Hepatitis, tuberculosis.
  • Consumption of immunosuppressive medications such as corticosteroids (except topical).

Key Trial Info

Start Date :

August 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT06195618

Start Date

August 1 2025

End Date

June 1 2028

Last Update

June 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Facultad de Medicina - Universidad Nacional de Colombia

Bogotá, Bogota D.C., Colombia, 111321